Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11981725 Antigen binding molecules targeting SARS-CoV-2

Overview Structured Data Issues Contributors Activity

Is a

1

Date Filed

January 6, 2023

1

Date of Patent

May 14, 2024

1

Patent Application Number

18151194

1

Patent Citations

US Patent 8546543 Fc variants that extend antibody half-life

1

US Patent 9803023 Fc variants with altered binding to FcRn

1

US Patent 10336818 Fc variants with altered binding to FcRn

1

US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

1

US Patent 11168128 Antibodies against SARS-CoV-2 and methods of using the same

1

US Patent 11028167 Anti-SARS-Cov-2 antibodies derived from 3bgf

1

US Patent 11192940 Compounds specific to coronavirus S protein and uses thereof

1

US Patent 8088376 Fc variants with altered binding to FcRn

1

US Patent 8394925 Fc variants with altered binding to FcRn

1

Patent Inventor Names

John Ingraham

1

Alexis Hiram Ramos

1

Jenhan Tao

1

Robin Jeffrey Green

1

Gevorg Grigoryan

1

Ross Steven Federman

1

Cheuk Lun Leung

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

1

Patent Primary Examiner

Michael Szperka

1

Find more entities like US Patent 11981725 Antigen binding molecules targeting SARS-CoV-2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool